TOVX stock news · Theriva Biologics, Inc.
Get alerts for TOVX
Follow Theriva Biologics, Inc. (TOVX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TOVXFree on the App Store and Google Play, or on the web.
Theriva Biologics will do a reverse stock split on December 1, 2026, to meet NYSE American rules.
NeutralTheriva approved a 1-for-30 reverse stock split, set to take effect December 1, 2026. It aims to meet exchange share-price rules but does not change the company's business outlook.
Theriva Biologics will do a 1-for-30 reverse stock split starting December 1, 2026, to meet NYSE rules.
NeutralTheriva Biologics will combine 30 shares into 1, reducing outstanding shares from 45,892,668 to about 1,529,756. The move aims to meet exchange price rules but generally leaves owners' proportional stakes unchanged.